NCT05810545View on ClinicalTrials.gov

Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity

CompletedOBSERVATIONAL
Enrollment

256,659

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Birth WeightSmall for Gestational Age at DeliveryLarge for Gestational Age at Delivery (Macrosomia)Diabetes, GestationalHypertension in PregnancyPreeclampsiaCongenital Malformation
Interventions
OTHER

Per- and polyfluoroalkyl substances (PFAS)

Assess the association between exposure to per- and polyfluoroalkyl substances (PFAS) via drinking water in pregnancy and birth outcomes (i.e. growth retardation, premature birth, and congenital developmental defects) and maternal morbidity (gestational hypertension, diabetes and preeclampsia) in a prospective population-wide register based cohort.

All Listed Sponsors
collaborator

The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)

OTHER_GOV

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Statistics Sweden

UNKNOWN

collaborator

National Board of Health and Welfare, Sweden

OTHER_GOV

collaborator

Swedish University of Agricultural Sciences

OTHER

collaborator

Swedish Food Agency

UNKNOWN

lead

Karolinska Institutet

OTHER

NCT05810545 - Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity | Biotech Hunter | Biotech Hunter